We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$149M
AUM Growth
+$18.4M
Cap. Flow
+$15.4M
Cap. Flow %
10.36%
Top 10 Hldgs %
23.06%
Holding
807
New
78
Increased
152
Reduced
163
Closed
88

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$837K
2
ENB icon
Enbridge
ENB
+$643K
3
ABBV icon
AbbVie
ABBV
+$597K
4
IVZ icon
Invesco
IVZ
+$518K
5
CVS icon
CVS Health
CVS
+$501K

Sector Composition

Rank Sector Weight
1 Technology 14.14%
2 Healthcare 10.85%
3 Consumer Staples 8.36%
4 Industrials 8.19%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEO
526
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$11K 0.01%
750
XLNX
527
DELISTED
Xilinx Inc
XLNX
$11K 0.01%
+92
New +$10.7K
HIVE
528
DELISTED
Aerohive Networks
HIVE
$11K 0.01%
2,500
BPMC
529
DELISTED
Blueprint Medicines
BPMC
$10K 0.01%
105
MITK icon
530
Mitek Systems
MITK
$834M
$10K 0.01%
1,000
MPT
531
Medical Properties Trust
MPT
$2.81B
$10K 0.01%
550
RSG icon
532
Republic Services
RSG
$65.7B
$10K 0.01%
120
RYN icon
533
Rayonier
RYN
$6.55B
$10K 0.01%
376
SA
534
Seabridge Gold
SA
$3.35B
$10K 0.01%
755
VPG icon
535
Vishay Precision Group
VPG
$914M
$10K 0.01%
240
XLP icon
536
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$10K 0.01%
166
+1
+0.6% +$57
CEQP
537
DELISTED
Crestwood Equity Partners LP
CEQP
$10K 0.01%
284
ARRY
538
DELISTED
Array Biopharma Inc
ARRY
$10K 0.01%
214
-323
-60% -$9.07K
DHC
539
Diversified Healthcare Trust
DHC
$2.14B
$9K 0.01%
1,050
INSM icon
540
Insmed
INSM
$28.6B
$9K 0.01%
369
MEDP icon
541
Medpace
MEDP
$16.5B
$9K 0.01%
131
CALY
542
Callaway Golf Company
CALY
$3.14B
$9K 0.01%
500
WK icon
543
Workiva
WK
$3.54B
$9K 0.01%
+150
New +$8.04K
XLG icon
544
Invesco S&P 500 Top 50 ETF
XLG
$11B
$9K 0.01%
450
TVRD
545
Tvardi Therapeutics
TVRD
$23.4M
$9K 0.01%
11
NPTN
546
DELISTED
NEOPHOTONICS CORP
NPTN
$9K 0.01%
2,131
IOTS
547
DELISTED
Adesto Technologies Corp
IOTS
$9K 0.01%
+1,136
New +$8.15K
AKTX
548
Akari Therapeutics
AKTX
$12.3M
$8K 0.01%
5
BIDU icon
549
Baidu
BIDU
$37.2B
$8K 0.01%
70
CARG icon
550
CarGurus
CARG
$3.47B
$8K 0.01%
+218
New +$8.19K

Similar funds

Truvestments Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Truvestments Capital held 807 positions worth $149M, up 14% from $130M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Truvestments Capital deployed $15.4M of net new capital in Q2 2019, opening 78 new positions and adding to 152 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 4,043 shares worth $862K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $1.23M trimmed.

  • Truvestments Capital's largest Q2 2019 buy was Berkshire Hathaway Class B: 4,043 shares worth $862K.
  • Truvestments Capital added most to Enbridge in Q2 2019, an estimated $643K increase.
  • Truvestments Capital's biggest Q2 2019 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.23M.
  • Truvestments Capital fully exited Blackstone in Q2 2019, selling an estimated $893K.
  • Truvestments Capital's ten largest holdings make up 23% of its $149M portfolio in Q2 2019.
  • Truvestments Capital opened 78 new positions and closed 88 in Q2 2019.
  • Truvestments Capital's portfolio value rose 14% quarter-over-quarter to $149M.

Based on Truvestments Capital's 13F filing for Q2 2019, filed 15 Jul 2019.